Sign in
4

Changes in Ownership

Pelthos Therapeutics Inc. Filed Acc 0001919246-26-000101

Director sold 786 shares at an average $26.16 ($20,561)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Pauls Matthew Director 2026-07-02 Sale 10b5-1 −692 $26.00 $17,989 14,458 D: show line 1 in the form
Pauls Matthew Director 2026-07-02 Sale 10b5-1 −94 $27.36 $2,572 14,364 D: show line 2 in the form
Open-market sales · 786 sh · avg $26.16 · $20,561
Loading xslF345X06/wk-form4_1783458216.xml…